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 Chapter 15 
 Peripheral Blood Mononuclear Cells 
 Charlotte  R.  Kleiveland 
 Abstract  Numerous cell types are involved in maintenance of the intestinal tissue. 
However, the main players are cells of the epithelial lining and the immune system. 
Human peripheral blood mononuclear cells (PBMCs) are used to investigate the 
effect of food bioactives on various immune cells. These cells are easily isolated 
from blood of healthy donors or buffy coats (leukocyte concentrates, a by-product 
from hospital Blood Banks in the manufacturing of red blood cell and thrombocyte 
concentrates from anti-coagulated whole blood). PBMCs have a different composi-
tion, phenotype and activation status than cells found in intestinal tissue. However, 
this is a useful test system for investigation of immune modulatory effects of food 
bioactive compounds. Methods for the isolation of PBMCs and how they are used 
to investigate effects of bioactive components are discussed in this chapter. 
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15.1  Origin 
 Human peripheral blood mononuclear cells (PBMCs) are isolated from peripheral 
blood and identifi ed as any blood cell with a round nucleus (i.e. lymphocytes, 
monocytes, natural killer cells (NK cells) or dendritic cells). The cell fraction cor-
responding to red blood cells and granulocytes (neutrophils, basophils and eosino-
phils) is removed from whole blood by density gradient centrifugation. A gradient 
medium with a density of 1.077 g/ml separates whole blood into two fractions; 
PBMCs makes up the population of cells that remain in the low density fraction 
(upper fraction), whilst red blood cells and PMNs have a higher density and are 
found in the lower fraction (Fig.  15.1 ). 
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 PBMCs include lymphocytes (T cells, B cells, and NK cells), monocytes, and 
dendritic cells. In humans, the frequencies of these populations vary across indi-
viduals, but typically, lymphocytes are in the range of 70–90 %, monocytes from 10 
to 20 %, while dendritic cells are rare, accounting for only 1–2 %. The frequencies 
of cell types within the lymphocyte population include 70–85 % CD3 + T cells, 
5–10 % B cells, and 5–20 % NK cells. The CD3 + lymphocytes are composed of 
CD4 + and CD8 + T cells, roughly in a 2:1 ratio. After activation the CD4 + T cell 
subset may develop into diverse effector cell subsets, including Th1, Th2, Th17, 
Th9, Th22, follicular helper (Tfh) cells and different types of regulatory cells (Akdis 
et al.  2012 ; Crotty  2011 ; Tan and Gery  2012 ; Sakaguchi et al.  2008 ). The CD4 + 
helper T cells are essential mediators of immune homeostasis and infl ammation 
(Hirahara et al.  2013 ). 
15.2  Features and Mechanisms 
 Most of the PBMCs are naïve or resting cells without effector functions. In the 
absence of an ongoing immune response T cells, the largest fraction of the isolated 
PBMCs, are mainly present as naïve or memory T cells. The naïve T-cells have 
never encountered their cognate antigen before and are commonly characterized by 
the absence of activation markers like CD25, CD44 or CD69 and the absence of the 
memory marker CD45RO isoform. Antigen recognition by a naïve T cell may result 
in activation of the cell (described in detail in  Chap.  18 ), which will then enter a 
differentiation program and develop effector functions. Activated T cells may 
 Fig. 15.1  Schematic illustration of how to prepare the density gradient for isolation of PBMCs 
from blood ( a ,  b ) and where in the gradient the PBMCs ( grey layer ) are found after centrifugation 




further differentiate into memory T cells that are able to mount a faster and stronger 
immune response the second time the antigen is encountered. B cells are also 
present in blood as naïve cells with a surface-anchored antigen receptor. Upon 
encountering antigen, the B cell may become activated and differentiate into 
antibody-producing plasma cells. 
 In peripheral blood the frequency of lymphocytes with specifi city for a single 
antigen are low. Polyclonal activators are therefore used for in vitro stimulation as 
these will activate a large proportion of the lymphocytes, independently of their 
antigen specifi city. The most common activators are mitogenic lectins, carbohydrate- 
binding proteins that bind to a number of glycoproteins expressed on the plasma 
membrane of lymphocytes (Ashraf and Khan  2003 ). Also, polyclonal activation of 
T cells can be obtained by antibodies that specifi cally bind to CD3, alone or in 
combination with CD28. The most commonly used mitogenic lectins are phytohae-
magglutinin (PHA) and concanavalin A (con A) that mainly induce T cell prolifera-
tion, pokeweed mitogen (PWM) that induce T and B cell proliferation and 
lipopolysaccharide (LPS) which induce B cell proliferation and activation of mono-
cytes. Effects on the immune function of PBMCs are usually investigated by 
measuring changes in lymphocyte proliferation, characterization of cytokine 
secretion profi les or changes in gene expression. 
15.3  Stability, Consistency and Reproducibility 
 It is well known that multiple physiological factors such as nutritional status, 
hormone levels and infections/infl ammation will infl uence the reactivity of immune 
cells; hence, the composition of PBMCs will depend on donor and the donor’s 
physiological status. Compared to the use of cell lines, this can lead to increased 
inter- experimental variation when different donors are used. Although the use of 
different donors leads to increased variance, the strength of reproducing results with 
cells from several donors will support the generality of the results. 
15.4  Relevance to Human In Vivo Situation 
 PBMCs isolated from whole blood will be different from immune cells isolated 
from intestinal tissue or lymph nodes draining the intestine. Intraepithelial lympho-
cytes are predominantly CD8 + (90 %) cells whilst lymphocytes within the lamina 
propria are mainly CD4 + cells expressing a CD44 hi CD62L − effector memory phe-
notype which indicate that these are antigen-experienced cells (Shale et al.  2013 ). 
In addition, several populations of immune cells present in the intestinal mucosa is 
not present in blood i.e. B1 B cells, natural killer T cells (NKT cells) and innate 
lymphoid cells (ILCs). Upon infl ammatory signals, monocytes from blood will 
move into the site of infection and differentiate to myeloid antigen-presenting cells 
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which is a heterogeneous population of macrophages and dendritic cells (DCs) 
(Swiatczak and Rescigno  2012 ). Because of these differences in the phenotype of 
cells present in blood and in lamina propria of the gastrointestinal tract it can be 
expected that mononuclear cells isolated from blood will respond differently from 
lamina propria mononuclear cells. Care should therefore be taken in drawing con-
clusions about the mucosal immune response in the intestine from in vitro studies 
with PBMCs. 
15.5  General Protocol 
 Isolation of PBMCs is done from peripheral blood or buffy coats supplemented with 
anticoagulants (heparin, EDTA, citrate, ACD-A or citrate phosphate dextrose 
(CPD)). Blood is diluted with 2–4 volumes phosphate-buffered saline (PBS) pH-7.2. 
The more diluted blood samples the better purity of the mononuclear cells. Add 
35 ml of diluted blood to a 50 ml tube (Fig.  15.1a ). Place 10 ml of a density gradient 
medium with ρ = 1.077 g/ml (e.g. Ficoll-Paque PLUS) at the bottom of the tube with 
a 15 G hypodermic needle (or similar) (Fig.  15.1b ) before centrifugation at 400× g 
for 25 min at 20 °C in a swinging bucket rotor without brake. Using a brake during 
centrifugation will disturb the separation of the upper and lower fractions. Aspirate 
most of the upper layer leaving the mononuclear cells at the interphase (Fig.  15.1c ). 
Carefully transfer the mononuclear cells to a new 50 ml tube, fi ll the tube with PBS, 
mix and centrifuge at 300× g for 10 min at 20 °C (Fig.  15.1d ). Remove the superna-
tant completely and resuspend the cells in a small volume of PBS before diluting the 
cell suspension with 50 ml PBS and centrifuge at 200× g for 15 min at 20 °C. This 
step will remove platelets, and it should be repeated at least once. When most of the 
platelets are removed, resuspend the cells in complete RPMI 1640 with 10 % heat 
inactivated fetal calf serum (FCS), and count them. Cells can be used immediately 
or preserved and stored in liquid nitrogen. 
15.5.1  Study of Proliferative/Cytotoxic Activity 
 Dilute the test compounds in RPMI 1640 with additions as described above. Seed 
the PBMCs at a density of 1 × 10 5 cells/well in a 96 well plate. Incubate the PBMCs 
with serial dilutions of the test compound in triplicates at 37 °C in an atmosphere of 
5 % CO 2 and 100 % humidity. Measurement of effects on proliferative/cytotoxic 
responses must be done in the presence and absence of the mitogenic stimuli. An 
array of methods and kit-based assay systems are available for this purpose, for 
example incorporation of  3 H-thymidine or measurement of mitochondrial reductase 
with tetrazolium salts (MTT). The optimal concentrations of the polyclonal activa-
tors can be established by cultivating PBMCs in the presence of twofold dilutions of 
the activators. Effect of the test compound on proliferation/cytotoxicity should be 
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studied in combination with both optimal and suboptimal concentrations of the 
mitogenic stimuli. The vehicle control (solvent of the test compound stock) should 
be included too. As background control, RPMI 1640 with the test compound and 
activators can be used. As negative control, PBMCs in RPMI 1640 without both test 
compounds and activators should be used. 
15.5.2  Study of Infl ammatory Responses 
 Upon stimulation with polyclonal activators PBMCs will produce cytokines and 
up-regulate activation markers. Characterization of the cytokine profi le and changes 
in activation marker expression, especially on T cells, may provide information 
whether the response is in the direction of Th1, Th2, Th17 or regulatory T cells. 
Investigations of the cytokine profi le is most easily carried out by ELISA analysis 
of secreted cytokines in the culture supernatant. Alternatively, the number of cells 
producing the different cytokines can be studied after intracellular staining and 
analysis by fl ow cytometry. Also, changes in gene expression levels by qPCR can be 
informative. Test compounds should be diluted in RPMI 1640. Plate the PBMCs at 
a density of 1–2 × 10 6 cells/well in a 24 well plate. Incubate the PBMCs with a serial 
dilution of the test compound in the presence and absence of LPS (100 ng/ml), anti-
 CD3/CD28 or the above mentioned mitogenic lectins at 37 °C in an atmosphere of 
5 % CO 2 . Cytokines will be detectable in the culture supernatant after only a few 
hours. However, cytokines will be secreted with different kinetics, it will therefore 
be necessary to study the cytokine profi le at different time points. 
15.6  Assess Viability 
 In the case of the study of infl ammatory responses, the cytotoxicity of the test 
compound at varying concentrations should be tested for instance by using LDH 
or MTT. 
15.7  Experimental Read Out 
 PBMCs have been widely employed to assess several aspects of immune regulation. 
The physiological relevance of in vitro studies with PBMCs is debatable, but several 
reports have shown that these studies can be predictive for the in vivo situation. de 
Kivit et al. ( 2012 ) reported that increased galectin-9 expression in intestinal epithe-
lial cells and serum induced by dietary symbiotics in mice correlated with reduced 
acute allergic skin reactions and mast cell degranulation. Parallel studies with stim-
ulation of PBMCs with recombinant galectin-9, showed induction of development 
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of Th1 and Treg cells. CD3/CD28-activated PBMCs were incubated with either 
medium or increasing concentrations of recombinant galectin-9 for 24 h. The effect 
on T cell activation was assessed by analysis of surface markers by fl ow cytometry. 
Th1 cells were identifi ed as CD4 + , CD69 + and CXCR3 + and Treg cells as CD4 + , 
CD25 + and Foxp3 + . Further characterization of the cytokine profi le was used to sup-
port the results. Increased secretion of IFNγ and Il-10 suggest increased levels of 
Th1 and Treg cells, whilst a decrease in IL-17 supports suppression of Th17 cells. 
 Cytokine secretion is one of the most used outcomes for evaluating infl uence on 
immune responses and has been studied with a variety of different types of com-
pounds. For example, Schroecksnadel et al. reported immune modulatory effects of 
a vitamin K antagonist (Schroecksnadel et al.  2013 ). PBMCs were pre-incubated 
with the vitamin K antagonist for 30 min before the cells were stimulated with PHA 
for 48 h. The cytokines secreted into the supernatants were analyzed by ELISA. Also, 
in a recent report cytokine secretion and activation of mitogen-activated protein 
kinases (MAPK) in response to polysaccharides isolated from  Alchornea cordifolia 
(Kouakou et al.  2013 ) was studied. Evaluation of the effects of polysaccharides on 
the activation status of an array of different MAPKs was done using a phospho- 
MAPK kit. PBMCs were incubated with the test compound for 60 min before lysis 
of the cells. An array of methods and kit based assays are available for evaluation of 
the activation status of MAPK and other intracellular protein kinases. 
 Effect of polyphenolic extracts from  Carpobrotus rossii on cytokine release from 
PBMCs has been reported (Geraghty et al.  2011 ). The cytokine release induced by 
the polyphenolic extract was investigated in the presence and absence of stimulation 
with PHA and LPS. In this study, a multiplex cytokine profi ling kit (Luminex ® ) was 
used to determine cytokine concentrations in culture supernatants. 
 Several reports have used PBMCs to study the immunomodulatory effects of 
probiotic bacteria.  Lactobacillus plantarum genes involved in immune modulation 
were identified in a study with PBMCs (van Hemert et al.  2010 ). A total of 42 
 L. plantarum strains were evaluated for their capacity to stimulate cytokine produc-
tion in PBMCs. Comparison of strain-specifi c cytokine responses by PBMCs 
resulted in identifi cation of six candidate genetic loci with immune modulatory 
capacities. Ashraf et al. have recently reported effects of cell-surface extracts and 
metabolites from a probiotic organism on both cytokine production and induction of 
CD25 expression on PBMCs (Ashraf et al.  2014 ). 
15.8  Advantages, Disadvantages and Limitations 
of the System 
 The advantage of PBMCs is that it is an easy accessible source of human immune 
cells, as the cells are isolated form full blood or buffy coats. 
 Disadvantages and limitations of this model system is the phenotypic differences 
between peripheral mononuclear cells and immune cells of the intestinal mucosa. 
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15.9  Conclusions 
 Although PBMCs is an easy accessible source of human immune cells, there are 
two major points that are important to keep in mind. (1) These cells are blood 
mononuclear cells that will differ from immune cells found i.e. in intestinal tissues. 
(2) When using PBMC in in vitro experiments the cells will lack the environmental 
stimuli they would have been exposed to under normal in vivo conditions. Both of 
these points are of great importance for how immune cells responds to different 
stimuli and should be taken in to account when interpreting the results. 
 Open Access This chapter is distributed under the terms of the Creative Commons Attribution 
Noncommercial License, which permits any noncommercial use, distribution, and reproduction in 
any medium, provided the original author(s) and source are credited. 
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